Stay updated with breaking news from 69404d10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its price target trimmed by Piper Sandler from $13.00 to $9.00 in a report issued on Monday morning, Benzinga reports. The brokerage currently has a neutral rating on the biotechnology company’s stock. PACB has been the topic of a number of other reports. Barclays dropped their […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the nine ratings firms that are covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report)’s share price was up 7% during trading on Monday . The stock traded as high as $8.71 and last traded at $8.70. Approximately 2,680,003 shares changed hands during mid-day trading, a decline of 32% from the average daily volume of 3,921,585 shares. The stock had […]
Pacific Biosciences of California (NASDAQ:PACB – Free Report) had its price objective cut by Barclays from $14.00 to $9.00 in a research report report published on Friday morning, MarketBeat.com reports. They currently have an equal weight rating on the biotechnology company’s stock. PACB has been the topic of several other reports. KGI Securities assumed coverage […]
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) insider Christian O. Henry sold 96,844 shares of the firm’s stock in a transaction on Monday, September 18th. The shares were sold at an average price of $10.12, for a total value of $980,061.28. Following the completion of the sale, the insider now owns 1,106,095 […]